A carregar...
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancer
BRCA and poly-ADP ribose polymerase (PARP) regulate pathways of DNA repair. Due to the accumulation of mutations introduced by error-prone DNA repair, breast and ovarian cancers develop in the setting of BRCA deficiency. A series of recent clinical trials has tested the use of PARP inhibition as a t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Faculty of 1000 Ltd
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2948351/ https://ncbi.nlm.nih.gov/pubmed/20948822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/B2-10 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|